[AsCNP_O2] Oral Session 2
Childhood & Adolescent Disorders

[AsCNP-O2-9] Real-world effectiveness of ramelteon and suvorexant on delirium prevention in 967 patients with delirium risk factors

^○Kotaro HATTA¹, Yasuhiro KISHI², Ken WADA³, Takashi TAKEUCHI⁴, Naoko HASHIMOTO⁵, Kiyoko SUDA⁶, Toshihiro TAIRA⁷, Kazuo TSUCHIDA⁸, Takashi OHMORI⁵, Nobuya AKIZUKI⁶, Yuko NISHIO⁶, Yukiko NAKANISHI⁶, Chie USUI¹, Akiko KURATA⁹, Naoki HORIKAWA¹⁰, Hiroshi EGUCHI¹⁰, Shigeo ITO², Hitoshi MUTO⁴, Hiroyuki NAKAMURA¹¹, Naohisa UCHIMURA¹⁰ (1. Department of Psychiatry, Juntendo University Nerima Hospital, Tokyo, Japan, 2. Department of Psychiatry, Nippon Medical School Musashikosugi Hospital, Kawasaki, Japan, 3. Department of Psychiatry, Hiroshima City Hospital, Hiroshima, Japan, 4. Department of Psychiatry, Tokyo Medical and Dental University, Tokyo, Japan, 5. Department of Psychiatry, Tokushima Prefectural Central Hospital, Tokushima, Japan, 6. Department of Psychooncology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan, 7. Department of Psychiatry, Fukuyama City Hospital, Fukuyama, Japan, 8. Department of Psychiatry, Kurashiki Central Hospital, Kurashiki, Japan, 9. Department of Psychiatry and Neurosciences, Hiroshima University Hospital, Hiroshima, Japan, 10. Department of Psychiatry, Kurume University School of Medicine, Kurume, Japan, 11. Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan)